As of 2025-09-19, the Relative Valuation of 4D Molecular Therapeutics Inc (FDMT) is (98.49) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.10 USD, the upside of 4D Molecular Therapeutics Inc based on Relative Valuation is -1487.2%.
The range of the Relative Valuation is (77.95) - (99.37) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.7x - 23.7x | 22.4x |
| Forward P/E multiples | 18.6x - 27.7x | 24.5x |
| Fair Price | (77.95) - (99.37) | (98.49) |
| Upside | -1197.9% - -1499.6% | -1487.2% |
| Date | P/E |
| 2025-09-11 | -1.68 |
| 2025-09-10 | -1.65 |
| 2025-09-09 | -1.66 |
| 2025-09-08 | -1.66 |
| 2025-09-05 | -1.73 |
| 2025-09-04 | -1.57 |
| 2025-09-03 | -1.54 |
| 2025-09-02 | -1.46 |
| 2025-08-29 | -1.47 |
| 2025-08-28 | -1.47 |
| 2025-08-27 | -1.54 |
| 2025-08-26 | -1.55 |
| 2025-08-25 | -1.60 |
| 2025-08-22 | -1.69 |
| 2025-08-21 | -1.63 |
| 2025-08-20 | -1.63 |
| 2025-08-19 | -1.56 |
| 2025-08-18 | -1.73 |
| 2025-08-15 | -1.73 |
| 2025-08-14 | -1.69 |
| 2025-08-13 | -1.59 |
| 2025-08-12 | -1.46 |
| 2025-08-11 | -1.32 |
| 2025-08-08 | -1.34 |
| 2025-08-07 | -1.38 |
| 2025-08-06 | -1.36 |
| 2025-08-05 | -1.44 |
| 2025-08-04 | -1.25 |
| 2025-08-01 | -1.53 |
| 2025-07-31 | -1.07 |
| 2025-07-30 | -1.05 |
| 2025-07-29 | -1.04 |
| 2025-07-28 | -1.10 |
| 2025-07-25 | -1.09 |
| 2025-07-24 | -1.10 |
| 2025-07-23 | -1.12 |
| 2025-07-22 | -1.07 |
| 2025-07-21 | -1.01 |
| 2025-07-18 | -1.00 |
| 2025-07-17 | -1.04 |
| 2025-07-16 | -1.01 |
| 2025-07-15 | -0.99 |
| 2025-07-14 | -1.04 |
| 2025-07-11 | -1.02 |
| 2025-07-10 | -1.04 |
| 2025-07-09 | -1.05 |
| 2025-07-08 | -1.00 |
| 2025-07-07 | -0.94 |
| 2025-07-03 | -1.01 |
| 2025-07-02 | -1.03 |